baber/WOPTO huggingface dataset:
Patent JP-2023546536-A (JP)
Title: 線維症を処置する方法
IPC: A61K45/00
Filed: 2021-10-13
Abstract: 本明細書は、線維症、特に、肺線維症を処置するための方法および組成物を提供する。肺線維症は、特発性であってもよいし、肺の感染後に生じてもよい。肺感染は、ＳＡＲＳ－ＣｏＶ－２によるものであり得る。処置の結果として、肺機能は安定するか、または改善される。１つの局面は、Ｇｌｉ１のインヒビターを投与する工程を包含する、線維症を処置する方法である。Ｇｌｉ１の阻害は、間接的であり得る。いくつかの実施形態において、ＳＭＯのインヒビターは、Ｇｌｉ１を間接的に阻害するために使用される。
Patent JP-2023546991-A (JP)
Title: アマルガム化予備成形物
IPC: B23K35/14
Filed: 2021-08-31
Abstract: 【課題】アマルガム化予備成形物を提供する。【解決手段】本発明に係るアマルガム化予備成形物は、卑金属、及び前記卑金属中に分散された複数のタイプの固体粒子を含み、前記卑金属は１つの液体卑金属及び固体卑金属を含む。前記複数のタイプの固体粒子は、少なくとも、前記卑金属中に前記複数のタイプの固体粒子を制御可能に分散するために磁性領域に応答性の非反応性の磁性粒子、及び前記磁性領域下で前記卑金属と反応可能な反応性粒子を含んで構成する。
Patent MX-2007004136-A (MX)
Title: Fuel cartridge with an environmentally sensitive valve.
Inventor: SGROI ANTHONY JR
IPC: G05D23/00
Filed: 2005-10-03
Abstract: The present invention is directed to a fuel supply with an environmentally sensitivevalve. The environmentally sensitive valve is sensitive to the environmentalfactor(s) such as temperature, pressure or velocity. The valve may be configuredso that the valve automatically resets when the environmental triggering eventno longer exists.
Patent MX-2007008099-A (MX)
Title: Disposable dispensing and display carton for paper towels and other rolled products.
Inventor: HERMANS MICHAEL ALAN
IPC: B65D83/08
Filed: 2005-11-09
Abstract: A dispensing and display carton (10) in combination with a rolled product (14) is disclosed. The dispensing carton (10) and rolled product (14) combination generally comprises a disposable dispenser that is configured to hold a roll of tissue products, such as paper towels. The dispenser may be constructed, for instance, from paperboard, plastic or any other disposable material. Of particular advantage, the dispenser may be packaged with the roll of material and may be decorated to match or complement the roll of material.
Patent MX-2007008193-A (MX)
Title: Use of the fp header to signal the rnc that the node b has not been able to determine or has not been able to accurately determine the number of retransmissions.
Inventor: MALKAMAKI ESA
IPC: H04L1/1812
Filed: 2005-12-30
Abstract: The FP header is used to signal the RNC that the Node B has not been able to determine or has not been able to accurately determine the number of retransmissions. A first embodiment is to reserve a bit pattern for use in the `Number of HARQ retransmissions' field on the lub frame protocol DATA FRAME header to indicate that Node B does not know the actual number of retransmissions. A second embodiment is to define a one bit flag on Iub/lur FP DATA FRAME header to indicate that the value set in the "Number of HARQ Retransmissions" in the FP header is an estimated/guessed value by Node B or not.
Patent MX-2007009915-A (MX)
Title: Aerosol and injectable formulations of nanoparticulate benzodiazepine.
Inventor: LIVERSIDGE GARY
IPC: A61K9/72
Filed: 2006-02-15
Abstract: Described are nanoparticulate formulations of a benzodiazepine, such as lorazepam, that does not require the presence of polyethylene glycol and propylene glycol as stabilizers, and methods of making and using such formulations. The formulations are particularly useful in aerosol and injectable dosage forms, and comprise nanoparticulate benzodiazepine, such as lorazepam, and at least one surface stabilizer. The formulations are useful in the treatment of status epilepticus, treatment of irritable bowel syndrome, sleep induction, acute psychosis, and as a pre-anesthesia medication.
Patent MX-2007012131-A (MX)
Title: System and method for transformation of syndicated content for mobile delivery.
Inventor: BUCKLEY ADRIAN
IPC: H04L12/00
Filed: 2007-09-28
Abstract: A method and system for embedding metadata for mobile delivery into a syndicated content feed, the method having the steps of receiving content from a syndicated content provider; embedding into the content the metadata using a standard schema extension mechanism, thereby creating modified content; and publishing the modified content. Also, a delivery server and a method within the delivery server to repackage content into a single format wrapped content envelope for delivery.<IMAGE>.
Patent MX-2007013148-A (MX)
Title: Wireless communication method and wlan for signaling deferral management messages.
Inventor: ROY VINCENT
IPC: H04W28/24
Filed: 2006-04-13
Abstract: A deferral management method is implemented in a wireless local area network (WLAN) including an access point (AP) and a plurality of wireless transmit/receive units (WTRUs). The AP sends a deferral management capabilities request message to the WTRUs to determine the deferral management capabilities of the WTRUs. In response, each of the WTRUs sends a deferral management capabilities indicator message to the AP. The AP may also send a deferral management parameter set message to the WTRUs to indicate values for setting deferral management parameters. In response, each of the WTRUs may optionally send a deferral management parameter set execution confirmation message to the AP. The WTRUs may also set the values of various deferral management parameters in accordance with a certain rule specified in a deferral management rule message sent by the AP. Optionally, the WTRUs may respond to the AP with a deferral management rule execution confirmation message.
Patent MX-2007014171-A (MX)
Title: Functionalized films.
Inventor: DENOME FRANK WILLIAM
IPC: C11D17/04
Filed: 2006-05-10
Abstract: Process for making a functionalized substrate in the form of a water-soluble film carrying a coating of a functional composition, the process comprising applying to at least one side of the film an aqueous solution comprising one or more functional materials to form the coating wherein the coating is formed from a plurality of layers in a stepwise manner and/or the aqueous solution comprises a film insolubilizer agent.
Patent MX-2007015571-A (MX)
Title: Tanaproget compositions containing ethinyl estradiol.
Inventor: CHATLAPALLI RAMARAO
IPC: A61K9/14
Filed: 2006-06-07
Abstract: Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits containing the compositions, methods of contraception and hormone replacement therapy including administering a composition containing micronized tanaproget and ethinyl estradiol.
Patent MX-2008000212-A (MX)
Title: Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation.
Inventor: MALAMAS MICHAEL SOTIRIOS
IPC: C07D409/14
Filed: 2006-06-26
Abstract: The present invention provides a 2-amino-5-heteroaryl-5-phenylimidazolone compound of formula I. The present invention also provides methods for the use thereof to inhibit ??-secretase (BACE) and treat ??-amyloid deposits and neurofibrillary tangles.
Patent MX-2008001291-A (MX)
Title: Asymmetric catalytic reduction of oxcarbazepine.
Inventor: ZANOTTI-GEROSA ANTONIO
IPC: C07D223/22
Filed: 2006-04-21
Abstract: A process for preparing (S)-(+)- 10,11 -dihydro-10-hydroxy-5H- dibenz/b,f/azepine-5-carboxamide or (R)-(-)-10,l l-dihydro-10-hydroxy-5H- dibenz/b,f/azepine-5-carboxamide, by reduction of oxcarbazepine in the presence of a catalyst and a hydride source is disclosed. The catalyst is prepared from a combination of [RuX<sub>2 </sub>(L)]<sub>2</sub> wherein X is chlorine, bromine or iodine, and L is an aryl or aryl-aliphatic ligand, with a ligand of formula (A) or formula (B): wherein R<sup>1</sup> is chosen from C<sub>1-6</sub> alkoxy and C<sub>1-6</sub> alkyl, n is a number from 0 to 5, and when n is a number from 2 to 5, R<sup>1</sup> can be the same or different, and R<sup>2</sup> is alkyl, substituted alkyl, aryl, substituted aryl, alkaryl or substituted alkaryl. The hydride source is either NR<sup>3</sup>R<sup>4</sup>R<sup>5</sup> and formic acid, [R<sup>3</sup>R<sup>4</sup>R<sup>5</sup>NH][OOCH] and optionally formic acid, or [M][OOCH]<sub>x</sub> and formic acid, wherein R<sup>3</sup>, R<sup>4</sup> and R<sup>5</sup> are C<sub>1-6</sub> alkyl, M is an alkali metal or alkaline earth metal and x is 1 or 2. A pH from 6.5 to 8 is maintained during the process.
Patent MX-2008003242-A (MX)
Title: Oxygen-regulated microorganisms
Inventor: CAMPBELL JOHN WALTER
Filed: 2006-08-18
Abstract: The present invention relates to novel strains of microorganisms with oxygen-regulated metabolism. Microorganisms have higher growth rates and are more efficient than parenteral strains. The microorganisms can be used to produce a variety of products of interest, such as recombinant proteins, nucleic acids, such as DNA, amino acids and chemical
Patent MX-2008003389-A (MX)
Title: Plant yield improvement by group 3 lea expression.
Inventor: MOLINERO ANA ISABEL SANZ
IPC: C07K14/415
Filed: 2006-09-15
Abstract: The present invention concerns a method for increasing plant yield by modulating expression in a plant of a nucleic acid encoding an OsLEA3a polypeptide or a homologue thereof. One such method comprises introducing into a plant an OsLEA3a nucleic acid or variant thereof. The invention also relates to transgenic plants having introduced therein an OsLEA3a nucleic acid or variant thereof, which plants have increased yield and altered metabolic profile, relative to control plants. The present invention also concerns constructs useful in the methods of the invention.
Patent MX-2008011234-A (MX)
Title: Delayed-effect agronomic treatment agent, in particular for seed germination and plant development.
Inventor: GAUDILLAT MICHEL
IPC: A01N25/34
Filed: 2006-03-08
Abstract: Agent for the agronomic treatment of a living plant supported by a moist substrate, for example a soil, wherein said agent is in the solid and divided state, and comprises solid particles containing at least one active entity for the agronomic treatment, characterized in that each particle comprises: - a nucleus consisting of a grain of a solid material which is inert with respect to the substrate, comprising an inner developed surface area which is greater than its apparent surface area and, as a result, suitable for adsorption and/or absorption, - the active entity for agronomic treatment, absorbed into the grain and/or adsorbed at the surface of said grain, - a membrane encapsulating the nucleus comprising the active entity, consisting of at least one hydrophilic polymer which is permeable to the outside with respect to the active entity, when it is in direct or indirect contact with the moist substrate.
Patent MX-2008011871-A (MX)
Title: Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease.
Inventor: KLETZIEN ROLF F
IPC: A61P3/10
Filed: 2007-03-14
Abstract: The present invention relates to thiazolidinedione analogues that are useful for treating metabolic inflammation mediated diseases such as diabetes.
Patent MX-2008011968-A (MX)
Title: Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators.
Inventor: SLASSI ABDELMALIK
IPC: C07D401/06
Filed: 2007-03-29
Abstract: Compounds of Formula (I): Formula (I) wherein A, B, D, L, R1, R2, R3, R4, m, and n are as defined for Formula (I) in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
Patent MX-2008012146-A (MX)
Title: Anti-igf-ir antibodies and uses thereof.
Inventor: HARIHARAN KANDASAMY
IPC: C07K16/00
Filed: 2007-03-28
Abstract: The invention relates to antibodies which bind to insulin like growth factor receptor -1 (IGF-IR) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific human and murine monoclonal antibodies which inhibit IGF-lR-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies which block the ability of the ligands, insulin like growth factor 1 (IGF-I) and insulin like growth factor 2 (IGF-2) to bind to IGF-IR, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention further includes methods of diagnosing and treating cancer using antibodies of the invention.
Patent MX-2008012471-A (MX)
Title: Polyisoprene condoms.
Inventor: ATTRILL JULIE ANN
IPC: C08J3/20
Filed: 2007-03-12
Abstract: The present invention relates to processes for making synthetic polyisoprene latex and synthetic polyisoprene condoms. A process for making a compounded synthetic polyisoprene latex suitable for making a latex film comprises (a) compounding a synthetic polyisoprene latex with suitable compounding ingredients, (b) maturing the latex and optionally (c) storing the latex; characterised in that steps (a), (b) and (c) if included are carried out at a low temperature so as to minimise prevulcanisation of the latex. Condoms can be made from latexes produced according to the process of the invention. The present invention relates to processes for making synthetic polyisoprene latex and synthetic polyisoprene condoms. A process for making a compounded synthetic polyisoprene latex suitable for making a latex film comprises (a) compounding a synthetic polyisoprene latex with suitable compounding ingredients, (b) maturing the latex and optionally (c) storing the latex; characterised in that steps (a), (b) and (c) if included are carried out at a low temperature so as to minimise prevulcanisation of the latex. Condoms can be made from latexes produced according to the process of the invention. The present invention relates to pharmaceutical compositions and their uses in therapy. In particular, the invention relates to compositions comprising methotrexate, preferably wherein the compositions are for administration via the inhaled or intranasal route.
Patent MX-2008012874-A (MX)
Title: Feed formulations containing docosahexaenoic acid.
Inventor: KYLE DAVID J
IPC: A61K8/97
Filed: 2007-04-03
Abstract: The disclosure relates to an animal feed or feed ingredient containing from about 0.01% to 1.0% DHA, wherein all, or substantially all of the DHA comes from material that is of non-animal origin and the use of microbially-derived DHA at these low levels provides sufficient DHA for the optimal neurological development of the animal.
Patent MX-2008015031-A (MX)
Title: Methods of use and nutritional compositions of touchi extract.
Inventor: GREENBERG NORMAN ALAN
IPC: A23L11/00
Filed: 2007-05-24
Abstract: Disclosed is a method and composition for nutritional compositions containing -glucosidase inhibitors, and more specifically Touchi Extract and its uses in the treatment of many disorders. These disorders include diabetes, hyperlipidemia, obesity, Metabolic syndrome/Syndrome X, COPD, malabsorption, Crohn's disease, diarrhea, constipation, irritable bowel syndrome, human immunodeficiency virus, cystic fibrosis, non-alcoholic steatohepatitis, polycystic ovarian syndrome including associate infertility, and erectile dysfunction. Further, -glucosidase inhibitors, and more specifically Touchi Extract can be used to aid healing in critical care patients and for general wound healing. Additionally, -glucosidase inhibitors, including Touchi Extract can be used to enhance athletic performance.
Patent MX-2009002623-A (MX)
Title: Food product container.
Inventor: RATHBONE JONATHAN E
IPC: B65D83/04
Filed: 2007-09-06
Abstract: A food product container includes a base and a cover. the base includes an opening, a top, and a bottom. At least one wall extends between the top and the bottom to define a container volume with a height, a width, and a depth. The depth is smaller than the height and the widht. The cover is connected to the base and disposed over the opening. The cover includes a dispensing opening. A plurality of food products is disposed within the container volume. The length of the food product is greater than the depht of the container volume.
Patent MX-2009005441-A (MX)
Title: Polyolefin compositions.
Inventor: CIARAFONI MARCO
IPC: C08J5/18
Filed: 2007-10-10
Abstract: Polyo lefin compositions, comprising (percent by weight): 1) 55-80% of a homopolymer or copolymer of propylene, said copolymer containing up to 15% of ethylene and/or C4-C10 -olefin(s). 2) 20-45% of a copolymer of ethylene with one or more C4-C10 -olefin(s) containing from 10 to 40% of said C4-C10 -olefin(s); said compositions having values of MFR (230 Â°C, 2.16 kg) up to 20 g/10 min, a total content of ethylene of 20% or more, a total content of C4-C10 -olefin(s) of 4.5% or more, a ratio of the total content of ethylene to the total content of C4-C10 -olefin(s) of 2.3 or more, a total fract ion soluble in xylene at room temperature of 18 wt% or higher and flexural modulus, referred to the composition as a reactor grade, of more than 700 MPa.
Patent MX-2009006158-A (MX)
Title: Pyrimidyl derivatives as protein kinase inhibitors.
Inventor: VOSS EDGAR
IPC: A61P35/00
Filed: 2007-12-19
Abstract: Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
Patent MX-2009007241-A (MX)
Title: Winding carrier and use of a winding carrier.
Inventor: HAHM JUERGEN
IPC: B65H75/10
Filed: 2008-01-03
Abstract: The invention provides various aspects of an improvement of winding carriers. The proposed winding carrier enables for the first time to arrange both the thread reserve and the thread end reserve on a winding carrier such that they are protected when putting the bobbins together, yet easily accessible after the bobbins have been taken apart. Simultaneously the thread windings of two wound winding carriers come to rest at each other in a practically direct manner.
Patent MX-2009008629-A (MX)
Title: Multi-part mechanical press for flanged connections.
Inventor: MONTOYA ALBERTO TREVIA O
IPC: F16L23/12
Filed: 2009-08-12
Abstract: Described is a multi-part mechanical press, preferably a two-part press for flanged connections, which allow the flanged connections to be manipulated in pipes for the addition or removal of elements from the line, which multi-part design provides a totally mechanical installation, without modifying the pipe line originated by destructive or removal procedures or material addition. The installation of the press requires the use of flanged connections in the pipe. The press may be used in the mounting and dismounting of additional devices from the line, such as filters, plates, flow regulators, measuring elements, orifice plates and valves.
Patent MX-2009012375-A (MX)
Title: Use of iron chelator for the treatment of myocardial infarction.
Inventor: GLASSPOOL JOHN
IPC: A61K31/4196
Filed: 2008-05-12
Abstract: The present invention relates to a method of treating and/or preventing myocardial infarction comprising administering an iron chelator to a warm-blooded animal. The iron chelator is preferably 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic.
Patent MX-2009013207-A (MX)
Title: A catheter and a method and an apparatus for making such catheter.
Inventor: OLSEN JAN KENT
IPC: A61M27/00
Filed: 2008-04-15
Abstract: The present invention concerns a catheter for medical purposes, such as for insertion into a body opening for draining fluids, wherein the catheter comprises a flexible tube having a distal end region wherein the tube is provided with at least one draining opening, characterised in that the peripheral edge on the outside of the tube is provided with a curvature for creating a smooth transition between the exterior surface of the tube and the substantially radially oriented cut constituting the opening side and wherein said curvature is a rounded edge with a curvature radius between 0.2-0.6 mm. The invention further concerns a method of making such catheter and an apparatus for performing this method.
Patent MX-2010002848-A (MX)
Title: Efficient design of mdct / imdct filterbanks for speech and audio coding applications.
Inventor: REZNIK YURIY
IPC: G10L19/02
Filed: 2008-09-19
Abstract: A more efficient encoder/decoder is provided in which an N-point MDCT transform is mapped into smaller sized N/2 -point DCT-IV and/or DCT-II transforms with isolated pre-multiplications which can be moved to a prior or subsequent windowing stage. That is, the windowing operations may be merged with first/last stage multiplications in the core MDCT/IMDCT functions, respectively, thus reducing the total number of multiplications. Additionally, the MDCT may be systematically decimated by factor of 2 by utilizing a uniformly scaled 5-point DCT-II core function as opposed to the DCT-IV or FFT cores used in many existing MDCT designs in audio codecs. The modified windowing stage merges factors from a transform stage and windowing stage to obtain piece-wise symmetric windowing factors, which can be represented by a sub-set of the piece-wise symmetric windowing factors to save storage space. Such features offer appreciable reduction in complexity and less memory usage than the prior art.
Patent MX-2010004295-A (MX)
Title: Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas.
Inventor: LEAUTE-LABREZE CHRISTINE
IPC: A61K31/18
Filed: 2008-10-16
Abstract: The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present invention provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Patent MX-2010005378-A (MX)
Title: Cell selection method and mobile station.
Inventor: NAKAMURA TAKEHIRO
IPC: H04W60/04
Filed: 2008-11-14
Abstract: A cell selection method includes a process (A) of judging whether a first CSG cell satisfies predetermined conditions when a mobile station (UE) uses a first macrocell as a standby cell and a process (B) of changing the standby cell from the first macrocell to the first CSG cell when the mobile station (UE) determines that the first CSG cell satisfies the predetermined conditions.
Patent MX-2010008559-A (MX)
Title: Inhibitors for brassinosteroid signalling.
Inventor: JONAK CLAUDIA
IPC: A01P21/00
Filed: 2009-03-03
Abstract: The invention describes a compound having the formula (I), wherein X is F, C1, Br, or I; R1 i s CH3, C2H5, C2H4R3, C2H3R3R4, C3H7, C3H6R3 or C3H5R3R4; R2 is H, CH3, C2H5, C2H4R3 or C2H3R3R4; and R3 and R4 are, independently, X, OH or NH2 for the treatment of plants, for increasing plant growth.
Patent MX-2010012069-A (MX)
Title: Leishmania vaccine using sand fly salivary immunogen.
Inventor: FISCHER LAURENT BERNARD
IPC: G01N33/68
Filed: 2009-05-06
Abstract: The present invention provides vectors that contain and express in vivo or in vitro sand fly Lu. longipalpis salivary antigens that elicit an immune response in animal or human against Leishmania, vaccine compositions comprising said vectors and/or Lu. longipalpis salivary polypeptides, methods of vaccination against Leishmania, and kits for use with such methods and compositions.